Skip to main content
. Author manuscript; available in PMC: 2022 Jan 14.
Published in final edited form as: Int J Stroke. 2016 Jul 13;11(9):1009–1019. doi: 10.1177/1747493016660094

Table 1.

Baseline characteristics of 638 participants

Characteristics Antihypertensive treatment (n = 314) Control (n = 324) P value
Age, mean (SD), year 60.4 (10.1) 59.8 (10.7) 0.49
Men, n (%) 227 (72.3) 221 (68.2) 0.26
Education, mean (SD), year 7.9 (4.2) 7.4 (4.0) 0.13
Time from stroke onset to randomization, mean (SD), h 14.5 (12.2) 15.0 (12.3) 0.6
Systolic blood pressure, mean (SD), mmHg 167.7 (17.0) 167.1 (16.3) 0.64
Diastolic blood pressure, mean (SD), mmHg 97.4 (9.8) 98.9 (10.2) 0.06
Body mass index, mean (SD), kg/m2 25.0 (3.1) 24.8 (3.0) 0.56
NIH stroke scale score, median (IQR) 4.0 (3.0–7.0) 4.0 (3.0–7.0) 0.41
Disease history, n (%)
 Hypertension 240 (76.4) 254 (78.4) 0.55
 Hyperlipidemia 19 (6.1) 24 (7.4) 0.49
 Diabetes mellitus 57 (18.2) 52 (16.1) 0.48
 Coronary heart disease 29 (9.2) 39 (12.0) 0.25
 Current cigarette smoking, n (%) 122 (38.9) 119 (36.7) 0.58
 Current alcohol drinking, n (%) 105 (33.4) 115 (35.5) 0.56
Ischemic stroke type, n (%)
 Thrombotic 210 (66.9) 213 (65.7) 0.76
 Embolic 8 (2.6) 15 (4.6) 0.16
 Lacunar 98 (31.2) 103 (31.8) 0.87

Data are presented as number of patients with variable present (%), mean (SD), or median (interquartile range).